×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
GLYC – glycomimetics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
GLYC
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/24
02:06 am
glyc
GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
12/16
02:06 am
glyc
GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
12/8
02:04 am
glyc
GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
11/30
03:03 am
glyc
GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
11/22
03:37 am
glyc
GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
11/14
03:11 am
glyc
GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
11/12
08:00 am
glyc
Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024
Medium
Report
Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024
11/6
07:00 am
glyc
GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting
Low
Report
GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/27
02:23 pm
glyc
Form SC 13G GLYCOMIMETICS INC Filed by: Logos Global Management LP
Low
Report
Form SC 13G GLYCOMIMETICS INC Filed by: Logos Global Management LP
11/13
04:31 pm
glyc
Form 10-Q GLYCOMIMETICS INC For: Sep 30
Low
Report
Form 10-Q GLYCOMIMETICS INC For: Sep 30
11/12
04:31 pm
glyc
Form SC 13G/A GLYCOMIMETICS INC Filed by: Invus Global Management, LLC
Low
Report
Form SC 13G/A GLYCOMIMETICS INC Filed by: Invus Global Management, LLC
11/7
04:51 pm
glyc
Form DEFA14A GLYCOMIMETICS INC
Medium
Report
Form DEFA14A GLYCOMIMETICS INC
11/7
04:46 pm
glyc
Form 8-K GLYCOMIMETICS INC For: Nov 07
Medium
Report
Form 8-K GLYCOMIMETICS INC For: Nov 07
11/6
05:42 pm
glyc
Form SC 13G GLYCOMIMETICS INC Filed by: RA CAPITAL MANAGEMENT, L.P.
Medium
Report
Form SC 13G GLYCOMIMETICS INC Filed by: RA CAPITAL MANAGEMENT, L.P.
11/4
04:26 pm
glyc
Form SC 13D GLYCOMIMETICS INC Filed by: Adage Capital Management, L.P.
Medium
Report
Form SC 13D GLYCOMIMETICS INC Filed by: Adage Capital Management, L.P.
11/4
02:02 pm
glyc
Form SCHEDULE 13G/A GLYCOMIMETICS INC Filed by: Weinstein Benjamin
Medium
Report
Form SCHEDULE 13G/A GLYCOMIMETICS INC Filed by: Weinstein Benjamin
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
9/9
Form SC 13G/A GLYCOMIMETICS INC Filed by: BIOTECHNOLOGY VALUE FUND L P
14.1%
4/9 Form SC 13G/A GLYCOMIMETICS INC Filed by: WELLINGTON MANAGEMENT GROUP LLP 13.2%
8/15 Form 4 GLYCOMIMETICS INC For: Aug 13 Filed by: JUNIUS DANIEL M 11.5%
8/5 GlycoMimetics Inc (NASDAQ: GLYC) had its price target lowered by analysts at HC Wainwright from $23.00 to $18.00. They now have a "buy" rating on the stock. 9.6%
1/6 Form 4 GLYCOMIMETICS INC For: Jan 06 Filed by: Magnani John L. 6.5%
9/5 GlycoMimetics to Present at Two Upcoming Investor Conferences 6.1%
11/7 GlycoMimetics Inc (NASDAQ: GLYC) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 6.0%
10/31 GlycoMimetics to Report Third Quarter 2019 Financial Results on November 7, 2019 5.3%
5/4 GlycoMimetics (GLYC) Q1 2019 Earnings Call Transcript [The Motley Fool] 5.2%
11/13 GlycoMimetics to Present at Two Upcoming Investor Conferences 5.0%
4/9 Form SC 13G/A GLYCOMIMETICS INC Filed by: WELLINGTON MANAGEMENT GROUP LLP 13.2%
8/15 Form 4 GLYCOMIMETICS INC For: Aug 13 Filed by: JUNIUS DANIEL M 11.5%
8/5 GlycoMimetics Inc (NASDAQ: GLYC) had its price target lowered by analysts at HC Wainwright from $23.00 to $18.00. They now have a "buy" rating on the stock. 9.6%
1/6 Form 4 GLYCOMIMETICS INC For: Jan 06 Filed by: Magnani John L. 6.5%
9/5 GlycoMimetics to Present at Two Upcoming Investor Conferences 6.1%
11/7 GlycoMimetics Inc (NASDAQ: GLYC) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 6.0%
10/31 GlycoMimetics to Report Third Quarter 2019 Financial Results on November 7, 2019 5.3%
5/4 GlycoMimetics (GLYC) Q1 2019 Earnings Call Transcript [The Motley Fool] 5.2%
11/13 GlycoMimetics to Present at Two Upcoming Investor Conferences 5.0%
TOP News Decliners
8/4
GlycoMimetics Inc (NASDAQ: GLYC) was downgraded by analysts at Piper Jaffray Companies from an "overweight" rating to a "neutral" rating.
-46.7%
11/21 Form 8-K GLYCOMIMETICS INC For: Nov 21 -16.9%
4/28 GlycoMimetics Inc (NASDAQ: GLYC) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -8.2%
11/16 GlycoMimetics Inc (NASDAQ: GLYC) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. -8.0%
11/21 GlycoMimetics Inc (NASDAQ: GLYC) had its price target lowered by analysts at Roth Capital from $12.00 to $9.00. -7.1%
6/10 Form SC 13G GLYCOMIMETICS INC Filed by: Invesco Ltd. -7.1%
1/24 Form 4 GLYCOMIMETICS INC For: Jan 22 Filed by: King Rachel K. -6.1%
7/24 GlycoMimetics Inc (NASDAQ: GLYC) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -6.0%
1/7 Form 8-K GLYCOMIMETICS INC For: Jan 02 -5.7%
11/9 GlycoMimetics' (GLYC) CEO Rachel King on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] -5.4%
11/21 Form 8-K GLYCOMIMETICS INC For: Nov 21 -16.9%
4/28 GlycoMimetics Inc (NASDAQ: GLYC) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -8.2%
11/16 GlycoMimetics Inc (NASDAQ: GLYC) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. -8.0%
11/21 GlycoMimetics Inc (NASDAQ: GLYC) had its price target lowered by analysts at Roth Capital from $12.00 to $9.00. -7.1%
6/10 Form SC 13G GLYCOMIMETICS INC Filed by: Invesco Ltd. -7.1%
1/24 Form 4 GLYCOMIMETICS INC For: Jan 22 Filed by: King Rachel K. -6.1%
7/24 GlycoMimetics Inc (NASDAQ: GLYC) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -6.0%
1/7 Form 8-K GLYCOMIMETICS INC For: Jan 02 -5.7%
11/9 GlycoMimetics' (GLYC) CEO Rachel King on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] -5.4%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: